Insomnia symptoms during the COVID-19 pandemic: an examination of biopsychosocial moderators.
COVID-19
Insomnia symptoms
Moderators
Pandemic
Sleep
Journal
Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
13
11
2020
revised:
04
02
2021
accepted:
08
02
2021
pubmed:
5
3
2021
medline:
27
4
2022
entrez:
4
3
2021
Statut:
ppublish
Résumé
Healthy sleep is vital for physical and psychological health, and poor sleep can result in a myriad of negative physical and psychological outcomes. Insomnia symptoms often manifest as a result of acute life stressors or changes, and COVID-19 experiences may be one such stressor. Other known predisposing factors to insomnia may moderate the impact of COVID-19 experiences on sleep. The present study aimed to determine current levels of insomnia severity in a US sample, to investigate the relation of COVID-19 experiences to insomnia symptoms, and to determine which individuals are most susceptible to this association. Data were drawn from a larger online survey investigating sleep and health outcomes across the lifespan. COVID-19 experiences were assessed with the exposure and impact subscales of the CAIR Pandemic Impact Questionnaire (C-PIQ). The Insomnia Severity Index (ISI) measured insomnia symptoms. Biological, psychological, and social moderators were measured using other brief self-report measures. Insomnia symptoms prevalence was as follows: moderate-to-severe symptoms (25.5%), subthreshold symptoms (37.7%), and no symptoms (36.7%). Individuals' COVID-19 experiences significantly predicted insomnia symptom severity [F(1,997) = 472.92, p < 0.001, R Although negative experiences with COVID-19 are associated with worse insomnia symptoms, this relationship is not the same for everyone.
Sections du résumé
OBJECTIVE/BACKGROUND
Healthy sleep is vital for physical and psychological health, and poor sleep can result in a myriad of negative physical and psychological outcomes. Insomnia symptoms often manifest as a result of acute life stressors or changes, and COVID-19 experiences may be one such stressor. Other known predisposing factors to insomnia may moderate the impact of COVID-19 experiences on sleep. The present study aimed to determine current levels of insomnia severity in a US sample, to investigate the relation of COVID-19 experiences to insomnia symptoms, and to determine which individuals are most susceptible to this association.
METHODS
Data were drawn from a larger online survey investigating sleep and health outcomes across the lifespan. COVID-19 experiences were assessed with the exposure and impact subscales of the CAIR Pandemic Impact Questionnaire (C-PIQ). The Insomnia Severity Index (ISI) measured insomnia symptoms. Biological, psychological, and social moderators were measured using other brief self-report measures.
RESULTS
Insomnia symptoms prevalence was as follows: moderate-to-severe symptoms (25.5%), subthreshold symptoms (37.7%), and no symptoms (36.7%). Individuals' COVID-19 experiences significantly predicted insomnia symptom severity [F(1,997) = 472.92, p < 0.001, R
CONCLUSIONS
Although negative experiences with COVID-19 are associated with worse insomnia symptoms, this relationship is not the same for everyone.
Identifiants
pubmed: 33658155
pii: S1389-9457(21)00116-7
doi: 10.1016/j.sleep.2021.02.018
pmc: PMC8364920
mid: NIHMS1678643
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
175-178Subventions
Organisme : NIA NIH HHS
ID : K23 AG049955
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Références
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
Depress Anxiety. 2015 Sep;32(9):664-70
pubmed: 26047492
Brain Behav Immun. 2020 Aug;88:901-907
pubmed: 32437915
Clin Geriatr Med. 2018 May;34(2):205-216
pubmed: 29661333
J Clin Sleep Med. 2020 Aug 15;16(8):1417-1418
pubmed: 32351206
Health Psychol Open. 2020 Apr 4;7(1):2055102920913235
pubmed: 32284871
Psychiatry Res. 2020 Aug;290:113134
pubmed: 32505030
Curr Psychiatry Rep. 2018 Aug 9;20(9):69
pubmed: 30094679
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
Sleep Med. 2016 Aug;24:109-118
pubmed: 27810176
Sleep Health. 2017 Oct;3(5):383-388
pubmed: 28923198
Int J Cardiol. 2016 Sep 15;219:231-9
pubmed: 27336192
J Sleep Res. 2020 Aug;29(4):e13052
pubmed: 32246787
Psychosom Med. 2002 Mar-Apr;64(2):258-66
pubmed: 11914441
Psychiatry Res. 2020 Jul;289:113076
pubmed: 32434093
J Clin Psychol. 2020 Oct;76(10):1972-1983
pubmed: 32410237
Perspect Psychol Sci. 2011 Jan;6(1):3-5
pubmed: 26162106
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
Br J Health Psychol. 2012 May;17(2):420-31
pubmed: 22106955
Psychiatry Res. 2020 Aug;290:113128
pubmed: 32563951
Sleep Med. 2010 May;11(5):470-8
pubmed: 20388566
Sleep. 2007 Mar;30(3):274-80
pubmed: 17425223
Psychiatry Res. 2021 Jan;295:113599
pubmed: 33285346
Med Care. 2003 Nov;41(11):1284-92
pubmed: 14583691
Psychiatr Clin North Am. 1987 Dec;10(4):541-53
pubmed: 3332317